HOME >> MEDICINE >> NEWS
Data showed improved quality of life and patient satisfaction with SYMBICORT

Wilmington, DE May 22, 2007 New data demonstrated that the combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate dihydrate), led to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol) or placebo. The results from these two 12-week randomized, double-blind trials were presented at the American Thoracic Society (ATS) 2007 International Conference held in San Francisco, May 18-23.

"Asthma is a chronic disease that can have a significant effect on patients' day-to-day routine, including participating in activities, such as walking to the store or even playing with their children," said Dr. Kevin R. Murphy, Clinical Professor, University of Nebraska Medical Center. "For the millions of asthma sufferers in the U.S., and especially for those whose condition is not adequately controlled with their current medication, SYMBICORT will provide a new option for patients to help manage and control their asthma, allowing them to get back to their daily activities."

SYMBICORT is a recently approved, combination therapy indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older. SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of asthma. Studies of patients treated with SYMBICORT demonstrated clinically significant improvement in lung function occurring within 15 minutes of beginning treatment. SYMBICORT has safety data in long-term studies of up to one year, and has a robust cardiac safety profile.

"The studies presented at this year's ATS conference provided valuable data on asthma control and asthma-related quality of life with SYMBICORT," said Chris O'Brien, Senior Director, Medical Science, AstraZeneca. "Asthma sufferers will have a new, rapid-acting combination treatment to help them achieve asthma control."

Administere
'"/>

Contact: Tracy Knudsen
Tracy.Knudsen@astrazeneca.com
302-885-1933
AstraZeneca
22-May-2007


Page: 1 2 3

Related medicine news :

1. New analysis showed UC patients in clinical remission had higher rates of employment
2. ROZEREM (ramelteon) showed significant reduction in time to fall asleep
3. New study showed ramelteon helped adults with chronic insomnia fall asleep, sleep longer
4. LSUHSC awarded designation resulting in improved patient safety and outcomes
5. ACP supports improved access to information on relative strengths and weaknesses
6. Performance-related financial incentives for hospitals not linked with improved quality of care
7. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
8. Alzheimers weight gain initiative also improved patients intellectual abilities
9. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes
10. New study reports improved treatment and reduced mortality for patients with heart failure
11. Lymph node evaluation linked to improved survival for colon cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2020)... ... February 26, 2020 , ... ... 1pm EST with featured speaker Cristian Ionescu-Zanetti, PhD, Chief Technology Officer, Fluxion Biosciences ... IsoFlux system is a bench-top solution for high-sensitivity circulating tumor cell (CTC) enrichment ...
(Date:2/26/2020)... ... February 26, 2020 , ... ... the launch of its new HealthBus Worklflows solution, which will be showcased at ... deploying of client-specific health data exchange workflows to scenarios in days using a ...
(Date:2/23/2020)... ... February 22, 2020 , ... Although many people thrive on ... reveals that some people who dismiss compliments struggle with their sense of ... who took the Emotional Intelligence Test, Queendom researchers focused on two ...
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... that it is now offering a 10 percent grand opening discount 0n its ... percent off all purchases," said Osmay Gonzalez, spokesperson for Baby Blendy LLC, a ...
(Date:2/21/2020)... ... February 21, 2020 , ... Used for years as a ... traction as a viable replacement for invasive cosmetic surgery, such as breast augmentation. ... remain the market leader for the expected robust growth of autologous fat grafting ...
Breaking Medicine News(10 mins):
(Date:2/28/2020)... ... February 28, 2020 , ... At the very heart of ... no deterent to mandatory attendance in crowded conditions at the church in Daegu, South ... with the disease. , In America, we too have our gathering places where one ...
(Date:2/28/2020)... ... February 28, 2020 , ... Jason Colleran, Founder of The Perfect ... throwing support sleeve. The Perfect Arm product made its first appearance last January at ... and won “Best of Show” for the most innovative baseball product. , This company ...
(Date:2/28/2020)... (PRWEB) , ... February 27, 2020 , ... This Women’s ... history with VA. , “For the Department of Veterans Affairs, Women’s History Month ... proud of the role we play in the remaining chapters of their story,” said ...
Breaking Medicine Technology:
Cached News: